Medicare Enrolled

Dr. Mitchell Engle, M.D., PH.D.

Pain Medicine · Houston, TX
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1515 HOLCOMBE BLVD, Houston, TX 77030
7137926161
In practice since 2008 (17 years)
NPI: 1790946051 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Engle from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Engle? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Engle

Dr. Mitchell Engle is a pain medicine specialist in Houston, TX, with 17 years of NPI registration. Based on federal Medicare data, Dr. Engle performed 5,770 Medicare services across 1,710 unique beneficiaries.

Between the years covered by Open Payments, Dr. Engle received a total of $38,849 from 47 pharmaceutical and/or device companies across 667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Engle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 17 years in practice ▲ Top 10% volume in TX $38,849 industry payments

Medicare Practice Summary

Medicare Utilization ↗
5,770
Medicare services
Top 10% in TX for pain medicine
1,710
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~339 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Dexamethasone injection (steroid) 1,603 $0 $30
Steroid injection (triamcinolone) 1,548 $1 $65
Office visit, established patient (30-39 min) 911 $88 $250
Office visit, established patient (20-29 min) 320 $62 $200
Chronic care management, first 20 min/month 109 $47 $150
New patient office visit (45-59 min) 98 $121 $400
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint 94 $45 $800
Telephone medical discussion with physician, 11-20 minutes 92 $66 $220
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level 77 $233 $1,100
Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month 75 $52 $150
Drug injection, under skin or into muscle 68 $10 $165
Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month 57 $99 $200
Ultrasonic guidance for needle placement 53 $42 $150
Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician 52 $66 $315
Injection of substance into lower spine canal using imaging guidance 51 $180 $700
Chronic care management, additional 20 min/month 51 $35 $100
Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint 47 $211 $1,800
Injection, ketorolac tromethamine, per 15 mg 45 $0 $50
Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance 43 $169 $965
Injection of lower or sacral spine facet joint using imaging guidance, single level 41 $98 $1,200
Injection of lower or sacral spine facet joint using imaging guidance, second level 41 $38 $524
Joint injection, major joint 39 $45 $109
Telephone medical discussion with physician, 21-30 minutes 38 $85 $320
Fluoroscopic guidance for needle placement 37 $84 $225
Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint 34 $51 $900
Aspiration and/or injection of fluid large joint using ultrasound guidance 28 $81 $189
Injection of upper or middle spine facet joint using imaging guidance, single level 27 $117 $1,541
Injection of upper or middle spine facet joint using imaging guidance, second level 27 $45 $500
Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level 26 $85 $500
Injection of substance into middle or upper spine canal using imaging guidance 19 $181 $900
Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint 19 $196 $1,947
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.9% high complexity
67.2% medium
31.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$38,849
Total received (2018-2024)
Avg $5,550/year across 7 years
Top 7% in TX for pain medicine
47
Companies
667
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,638 (50.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,190 (49.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$21 (0.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$11,464
2023
$11,901
2022
$3,079
2021
$2,439
2020
$3,063
2019
$3,160
2018
$3,743

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Nalu Medical, Inc.
$20,926
Boston Scientific Corporation
$5,010
Abbott Laboratories
$2,717
Vertos Medical, Inc.
$1,818
Nevro Corp.
$1,627
Vertiflex, Inc.
$1,104
Relievant Medsystems, Inc.
$1,005
Medtronic USA, Inc.
$808
Saluda Medical Americas, Inc.
$555
BOSTON SCIENTIFIC CORPORATION
$281
Supernus Pharmaceuticals, Inc.
$260
Teva Pharmaceuticals USA, Inc.
$229
SPR Therapeutics, Inc
$221
Curonix LLC
$189
Medtronic, Inc.
$189
Collegium Pharmaceutical, Inc.
$188
SPINEFRONTIER, INC.
$182
PFIZER INC.
$140
Biohaven Pharmaceuticals, Inc.
$110
Stryker Corporation
$107
SI-BONE, Inc.
$104
ABBVIE INC.
$100
Horizon Therapeutics plc
$99
FIDIA PHARMA USA INC.
$80
Lilly USA, LLC
$71
SpineSmith Holdings, LLC
$69
XTANT MEDICAL INC
$63
TerSera Therapeutics LLC
$60
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$48
Nuvectra Corporation
$48
Radius Health, Inc.
$46
ARBOR PHARMACEUTICALS, INC.
$44
Averitas Pharma Inc.
$44
VERTEX PHARMACEUTICALS INCORPORATED
$36
GRT US Holding, Inc.
$36
Merz Pharmaceuticals, LLC
$34
Stratus Medical, LLC
$30
RedHill Biopharma Inc.
$25
Hikma Pharmaceuticals USA
$21
Daiichi Sankyo Inc.
$20
DePuy Synthes Sales Inc.
$20
Novartis Pharmaceuticals Corporation
$19
AstraZeneca Pharmaceuticals LP
$17
Amgen Inc.
$16
Biohaven Pharmaceutical Holding Company Ltd.
$12
Horizon Pharma plc
$12
BioDelivery Sciences International, Inc.
$11
Top 3 companies account for 73.8% of total payments
Associated products mentioned in payments ›
ADAPT · ADAPTIVESTIM · AIMOVIG · AJOVY · Aimovig · Algovita · Axium INS DRG IPG · BELBUCA · Belbuca · CoverEdge 32 · DUEXIS · EMGALITY · ETERNA · Evoke SCS · FIXATE · GENERAL PAIN MANAGEMENT · GENERAL THERAPIES · GENERAL - PAIN MANAGEMENT · GENERAL PAIN MANAGEMENT · Horizant · Hymovis · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Infinion 16 · Inspan · Intracept · Kloxxado · LIORESAL · LYRICA · MONOVISC · MOVANTIK · Morphabond ER · Movantik · NURTEC ODT · Nalu Neurostimulation System · OSTEOCOOL RF ABLATION · OXTELLAR XR · Omnia · PENNSAID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PRIALT · PROCLAIM · Prialt · Proclaim Family of SCS IPGs · Proclaim IPG · QULIPTA · QUTENZA · Qutenza · RELISTOR · RESTORE · REYVOW · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · Superion ISS · TROKENDI XR · Tymlos · VECTRIS · WAVEWRITER ALPHA · WaveWriter Alpha Prime 16 · XTAMPZA · Xeomin · iFuse Implant · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for pain medicine in TX.

Equivalent to $673 per 100 Medicare services performed
Looking for a pain medicine specialist in Houston?
Compare pain medicines in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pain medicines nearby

Geographic Context

Pain medicines within 10 mi
83
Per 100K population
1.7
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Engle is a clinical cardiology specialist, with above-average Medicare volume (top 10% in TX), with low-engagement industry engagement in the top 7% of TX peers, with 17 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Engle experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Engle performed 1,603 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Engle receive payments from pharmaceutical companies?
Yes. Dr. Engle received a total of $38,849 from 47 companies across 667 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Engle's costs compare to other pain medicines in Houston?
Dr. Engle's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Engle) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →